“Role of Tumor-Infiltrating Lymphocytes in Predicting Pathologic Complete Response in HER2-Positive Breast Cancer: An IMRAD-Based Analysis” (2025) Journal of Evidence-Based Medical Research, 1(02). doi:10.66687/jebmr.1.02.2025.22.